Qomolangma Acquisition Corp.: Nasdaq/NYSE listing notice — Qomolangma Acquisition Corp. liquidates, redeems shares at ~$10.88

Qomolangma Acquisition Corp.

Will redeem all outstanding public shares at ~$10.88 per share effective Dec 27, 2024.
Decision follows failure to consummate an initial business combination within allowed 36-month period.
Warrants will expire worthless; sponsor waived redemption rights on founder shares and private warrants.
Company notified Nasdaq of voluntary delisting on Jan 3, 2025; Form 25 and Form 15 to follow.
Sponsor unable to continue funding extension payments, board determined liquidation in best interest of stockholders.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Qomolangma Acquisition Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5550(a)(3)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: shareholders
Rules: 5550(a)(3)

Exact text from the filing

August 26, 2024, the Company received written notice from the Listing Qualifications Staff of Nasdaq (the “Staff”) indicating that the Company no longer complied with the Nasdaq Capital Market continued listing criteria set forth in Listing Rule 5550(a)(3), which requires the Company to maintain a minimum of 300 public holders (the “Notice”). The Notice provided the Company with 45 calendar days, or until October 10, 2024, to submit a plan to regain compliance. On November 13, 2024, the Staff issued a follow-up letter to the Company advising that the Staff determined that it was unable to gran

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001493152-25-001509

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.